Department of Radiology

Publications

2023

Stangl-Kremser J, Sun M, Ho B, Thomas J, Nauseef JT, Osborne JR, et al. Prognostic value of neutrophil-to-lymphocyte ratio in patients with metastatic castration-resistant prostate cancer receiving prostate-specific membrane antigen targeted radionuclide therapy. Prostate. 2023;83(14):1351-1357.

Abdel-Rahman SA, Zhang L, Gabr MT. Development of a high-throughput TR-FRET screening assay for LAG-3/FGL1 interaction. SLAS Discov. 2023;28(4):188-192.

Bodei L, R Tuttle M, Grewal RK, Mauguen A, Augensen F, Abusamra M, et al. Toward individualized dosimetry for radiopharmaceutical therapy in day-to-day clinical practice of nuclear oncology: overcoming heterogeneity of radiation-absorbed dose to tumor and critical organs. Eur J Nucl Med Mol Imaging. 2023.

Kratochwil C, Fendler WP, Eiber M, Hofman MS, Emmett L, Calais J, et al. Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT). Eur J Nucl Med Mol Imaging. 2023;50(9):2830-2845.

Manzoor S, Gabr MT, Nafie MS, Raza MK, Khan A, Nayeem SM, et al. Discovery of Quinolinone Hybrids as Dual Inhibitors of Acetylcholinesterase and Aβ Aggregation for Alzheimer's Disease Therapy. ACS Chem Neurosci. 2023.

Limberg J, Egan CE, Gray KD, Singh M, Loewenstein Z, Yang Y, et al. Activation of the JAK/STAT Pathway Leads to BRAF Inhibitor Resistance in BRAFV600E Positive Thyroid Carcinoma. Mol Cancer Res. 2023;21(5):397-410.

Chung SK, Vargas DB, Chandler CS, Katugampola S, Veach DR, McDevitt MR, et al. Efficacy of HER2-Targeted Intraperitoneal 225Ac α-Pretargeted Radioimmunotherapy for Small-Volume Ovarian Peritoneal Carcinomatosis. J Nucl Med. 2023;64(9):1439-1445.

Madhav H, Abdel-Rahman SA, Hashmi MA, Rahman MA, Rehan M, Pal K, et al. Multicomponent Petasis reaction for the identification of pyrazine based multi-target directed anti-Alzheimer's agents: In-silico design, synthesis, and characterization. Eur J Med Chem. 2023;254:115354.

Rosenberg JB, Fung EK, Dyke J, De BP, Lou H, Kelly J, et al. Positron Emission Tomography Quantitative Assessment of Off-Target Whole-Body Biodistribution of I-124-labeled Adeno-associated Virus Capsids Administered to Cerebral Spinal Fluid. Hum Gene Ther. 2023.

Jeitner TM, Azcona JA, Ables GP, Cooke D, Horowitz MC, Singh P, et al. Cystine rather than cysteine is the preferred substrate for β-elimination by cystathionine γ-lyase: implications for dietary methionine restriction. Geroscience. 2023.